Lyndiol (1 mg)--evaluation of a new low dose oral contraceptive.
Banerjee
S K
SK
D001208:Asia; D001695:Biology; D001769:Blood; D001794:Blood Pressure; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003906:Developing Countries; D004064:Digestive System; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006261:Headache; D006470:Hemorrhage; D007194:India; D008599:Menstruation Disturbances; D008796:Metrorrhagia; D009325:Nausea; D009461:Neurologic Manifestations; D010827:Physiology; D012106:Research; D012107:Research Design; D012816:Signs and Symptoms; D014839:Vomiting
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined
Asia; Biology; Bleeding; Blood Pressure--changes; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Effectiveness; Contraceptive Methods--side effects; Developing Countries; Diseases; Evaluation; Family Planning; Gastrointestinal Effects; Headache; Hemic System; India; Measurement; Menstruation Disorders; Metrorrhagia; Nausea; Neurologic Effects; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose--side effects; Oral Contraceptives--side effects; Physiology; Qualitative Evaluation; Research Methodology; Signs And Symptoms; Southern Asia; Use-effectiveness; Vomiting